Zaldiar

Zaldiar belongs to Grünenthal Pharma GmbH & Co. KG through Grünenthal GmbH. Zaldiar is owned by Grünenthal Pharma GmbH & Co. KG, headquartered in Germany. No. The ultimate owner of Zaldiar, Grünenthal Pharma GmbH & Co. KG, is headquartered in Germany, not in the United States.

Grünenthal is a global leader in pain management and related therapies, headquartered in Aachen, Germany. It is an independent, family-owned pharmaceutical company.

Grünenthal B.V. (for the Benelux region)